Your browser doesn't support javascript.
loading
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patients.
Ngai, Lok Lam; Ma, Connie Y; Maguire, Orla; Do, An D; Robert, Alberto; Logan, Aaron C; Griffiths, Elizabeth A; Nemeth, Michael J; Green, Cherie; Pourmohamad, Tony; van Kuijk, Bo J; Snel, Alexander N; Kwidama, Zinia W; Venniker-Punt, Bianca; Cooper, James; Manz, Markus G; Gjertsen, Bjørn T; Smit, Linda; Ossenkoppele, Gert J; Janssen, Jeroen J W M; Cloos, Jacqueline; Sumiyoshi, Teiko.
Afiliação
  • Ngai LL; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Ma CY; Department of Development of Science, Genentech, South San Francisco, CA, USA.
  • Maguire O; Flow and Image Cytometry Shared Resource, Buffalo, NY, USA.
  • Do AD; Department of Development of Science, Genentech, South San Francisco, CA, USA.
  • Robert A; Department of Development of Science, Genentech, South San Francisco, CA, USA.
  • Logan AC; Department of Medicine, UCSF, San Francisco, CA, USA.
  • Griffiths EA; Flow and Image Cytometry Shared Resource, Buffalo, NY, USA.
  • Nemeth MJ; Flow and Image Cytometry Shared Resource, Buffalo, NY, USA.
  • Green C; Department of Development of Science, Genentech, South San Francisco, CA, USA.
  • Pourmohamad T; Department of Biostatistics, Genentech, CA, USA.
  • van Kuijk BJ; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Snel AN; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Kwidama ZW; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Venniker-Punt B; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Cooper J; Department of Early Clinical Development, Genentech, South San Francisco, CA, USA.
  • Manz MG; Department of Medical Oncology and Hematology, University and University Hospital, Zurich, Switzerland.
  • Gjertsen BT; Section for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
  • Smit L; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Ossenkoppele GJ; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Janssen JJWM; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Cloos J; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Sumiyoshi T; Department of Development of Science, Genentech, South San Francisco, CA, USA.
Eur J Haematol ; 107(3): 343-353, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34053123
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células da Medula Óssea / Receptores Mitogênicos / Leucemia Mieloide Aguda / Biomarcadores Tumorais / Células Mieloides / Lectinas Tipo C / Mutação Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células da Medula Óssea / Receptores Mitogênicos / Leucemia Mieloide Aguda / Biomarcadores Tumorais / Células Mieloides / Lectinas Tipo C / Mutação Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda